Karyopharm Therapeutics KPTI 深 沪
等待开盘 08-04 09:30:00 美东时间
3.93
+0.120
+3.15%
华盛通- 最 高4.04
- 今 开3.71
- 成交量 6.41万股
- 最 低 3.71
- 昨 收 3.81
- 总市值 3395.48万
- 52周最高 16.95
- 市盈率 静 --
- 换手率 0.74%
- 52周最低 3.51
- 委 比 6.46%
- 总股本 863.99万
- 历史最高 735.075
- 量 比 0.93
- 振 幅 8.66%
- 历史最低 3.71
- 每 手 1
- 风险率 0.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多制药巨头扎堆做“减法”：20家药企7月宣布裁员
2025 年已经过半，裁员、削减成本，成为众多药企不得不面对的现实。据 Fierce Biotech 统计，仅在今年 7 月，就有 20 家药企宣布了裁员计划...
08-01 12:49
Karyopharm Therapeutics Explores Financing and Strategic Options
Karyopharm Therapeutics ( ($KPTI) ) has issued an update. Karyopharm Therapeuti...
07-11 19:47
HC Wainwright & Co. Assumes Karyopharm Therapeutics at Buy, Announces Price Target of $27
HC Wainwright & Co. analyst Robert Burns assumes Karyopharm Therapeutics (NASDAQ:KPTI) with a Buy rating and announces Price Target of $27.
07-11 18:15
Karat Packaging Inc. Announces Pricing of Secondary Offering of Common Stock
Karat Packaging Inc. announced the pricing of an underwritten secondary offering of 1.5 million shares of its common stock by certain management team members at $27.00 per share. Underwriters have a 30-day option to purchase an additional 225,000 shares. The offering is expected to close on June 12, 2025. The Company will not receive proceeds from the sale. BofA Securities and William Blair & Company are acting as joint lead book-runners. The off...
06-11 02:15
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEWTON, Mass., June 2, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the...
06-03 04:05
Karyopharm Therapeutics Stockholders Approve Equity Plan Amendment
The latest announcement is out from Karyopharm Therapeutics ( ($KPTI) ). At the...
05-30 04:53
Karyopharm’s Earnings Call: Clinical Gains Amid Financial Strains
Karyopharm Therapeutics INC (($KPTI)) has held its Q1 earnings call. Read on fo...
05-16 08:20
Karyopharm Announces Poster Presentation On Selinexor In Myelofibrosis At The 2025 EHA Annual Meeting
Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced its abstract has been selected for a poster presentation at the 2025 European
05-14 21:35
美股大行评级 | 潜在涨幅158.9%！蒙特利尔银行上调Disc Medicine目标价至120美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从112美元升至120美元</p> <p>• 巴克莱：维持Karyopharm Therapeutics(KPTI)"超配"评级，目标价从5美
05-14 08:48
